BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

NCT00602472 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1058

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: linagliptin
DRUG: placebo

Sponsor

Boehringer Ingelheim